首页> 外文期刊>细胞与分子免疫学:英文版 >SARS Vaccine: Progress and Challenge
【24h】

SARS Vaccine: Progress and Challenge

机译:SARS疫苗:进展与挑战

获取原文
获取原文并翻译 | 示例
           

摘要

Severe acute respiratory syndrome (SARS) emerged in 2002 as a severe and highly contagious infectious disease that rapidly spread to a number of different countries. The collaborative efforts of the global scientific community have provided, within a short period of time, substantial insights into the molecular biology and immunology of SARS-CoV. Although the outbreak has been contained, there is continuous concern that the virus may resurface into the human population through seasonal changes, animal reservoirs or laboratory accidents. The severe morbidity and mortality associated with SARS make it imperative that an effective vaccine be developed to prevent reemergence and epidemics in the future. Cellular & Molecular Immunology. 2005;2(2):101-105.
机译:严重急性呼吸道综合症(SARS)于2002年出现,是一种严重且具有高度传染性的传染病,已迅速传播到许多不同的国家。全球科学界的共同努力在短时间内提供了对SARS-CoV分子生物学和免疫学的实质性见解。尽管疫情已得到控制,但人们仍然担心该病毒可能会因季节变化,动物蓄水池或实验室事故而重新感染人类。与SARS相关的严重发病率和死亡率使得必须开发一种有效的疫苗来防止将来再次出现和流行。细胞与分子免疫学。 2005; 2(2):101-105。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号